175 related articles for article (PubMed ID: 11468501)
1. Assessing the clinical and economic burden of coronary artery disease: 1986-1998.
Eisenstein EL; Shaw LK; Anstrom KJ; Nelson CL; Hakim Z; Hasselblad V; Mark DB
Med Care; 2001 Aug; 39(8):824-35. PubMed ID: 11468501
[TBL] [Abstract][Full Text] [Related]
2. Acute coronary syndromes in Europe: 1-year costs and outcomes.
Taylor MJ; Scuffham PA; McCollam PL; Newby DE
Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
[TBL] [Abstract][Full Text] [Related]
3. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction.
Mahoney EM; Jurkovitz CT; Chu H; Becker ER; Culler S; Kosinski AS; Robertson DH; Alexander C; Nag S; Cook JR; Demopoulos LA; DiBattiste PM; Cannon CP; Weintraub WS;
JAMA; 2002 Oct; 288(15):1851-8. PubMed ID: 12377083
[TBL] [Abstract][Full Text] [Related]
4. Obesity and long-term clinical and economic outcomes in coronary artery disease patients.
Eisenstein EL; Shaw LK; Nelson CL; Anstrom KJ; Hakim Z; Mark DB
Obes Res; 2002 Feb; 10(2):83-91. PubMed ID: 11836453
[TBL] [Abstract][Full Text] [Related]
5. Costs of coronary heart disease and stroke: the case of Sweden.
Zethraeus N; Molin T; Henriksson P; Jönsson B
J Intern Med; 1999 Aug; 246(2):151-9. PubMed ID: 10447784
[TBL] [Abstract][Full Text] [Related]
6. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
[TBL] [Abstract][Full Text] [Related]
7. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy.
Brown RE; Henderson RA; Koster D; Hutton J; Simoons ML
Eur Heart J; 2002 Jan; 23(1):50-8. PubMed ID: 11741362
[TBL] [Abstract][Full Text] [Related]
9. Total first-year costs of acute coronary syndrome in a managed care setting.
Etemad LR; McCollam PL
J Manag Care Pharm; 2005 May; 11(4):300-6. PubMed ID: 15871640
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein IIb/IIIa receptor therapy in percutaneous coronary intervention and non-ST-segment elevation acute coronary syndromes. Estimating the economic implications.
Hillegass WB; Newman AR; Raco DL
Pharmacoeconomics; 2001 Jan; 19(1):41-55. PubMed ID: 11252545
[TBL] [Abstract][Full Text] [Related]
11. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
Tonkin AM; Eckermann S; White H; Friedlander D; Glasziou P; Magnus P; Kirby A; Mulray S; Denton M; Sallaberger M; Hunt D; Simes J;
Am Heart J; 2006 Jun; 151(6):1305-12. PubMed ID: 16781242
[TBL] [Abstract][Full Text] [Related]
13. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
McCollam P; Etemad L
J Invasive Cardiol; 2005 Jun; 17(6):307-11. PubMed ID: 16003005
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis.
Kourlaba G; Fragoulakis V; Maniadakis N
Appl Health Econ Health Policy; 2012 Jul; 10(4):261-71. PubMed ID: 22667992
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.
Rajagopal V; Lincoff AM; Cohen DJ; Gurm HS; Hu T; Desmet WJ; Kleiman NS; Bittl JA; Feit F; Topol EJ
Am Heart J; 2006 Jul; 152(1):149-54. PubMed ID: 16824845
[TBL] [Abstract][Full Text] [Related]
16. A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.
Gómez-Gerique JA; Casciano R; Stern L; Rejas J
Eur J Health Econ; 2004 Oct; 5(3):278-84. PubMed ID: 15714350
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study.
Fox KM; Wang L; Gandra SR; Quek RGW; Li L; Baser O
BMC Cardiovasc Disord; 2016 Jan; 16():13. PubMed ID: 26769473
[TBL] [Abstract][Full Text] [Related]
18. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
[TBL] [Abstract][Full Text] [Related]
19. Predictors of high-cost managed care patients with acute coronary syndrome.
Etemad LR; McCollam PL
Curr Med Res Opin; 2005 Dec; 21(12):1977-84. PubMed ID: 16368049
[TBL] [Abstract][Full Text] [Related]
20. Direct medical costs of coronary artery disease in the United States.
Russell MW; Huse DM; Drowns S; Hamel EC; Hartz SC
Am J Cardiol; 1998 May; 81(9):1110-5. PubMed ID: 9605051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
